Probabilities of treatment effects in complete or culprit-only revascularization for NSTEMI: A Bayesian re-analysis of the SLIM trial
Complete revascularization provides a high probability of clinically meaningful benefit in NSTEMI patients with MVD, primarily through reductions in nonfatal MI and repeat revascularization.
Authors
- Andrea Gabrio (ORCID: https://orcid.org/0000-0002-7650-4534)
- Tobias Pustjens (ORCID: https://orcid.org/0000-0003-4301-4843)
- Lux Árpád
- Arnoud W.J. van ‘t Hof (ORCID: https://orcid.org/0000-0002-2344-7564)
- Saman Rasoul
- Samuel Heuts
Institutions
- Maastricht University Medical Centre (NL)
- Maastricht University (NL)
Publication Details
- Journal
- American Heart Journal
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1016/j.ahj.2026.107369
- Primary Topic
- Coronary Interventions and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00